These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32983996)

  • 21. Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid.
    Ma C; Huang C; Tang D; Ye X; Li Z; Liu R; Mu N; Li J; Jiang R; Zhang J
    Front Oncol; 2019; 9():938. PubMed ID: 31641649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy.
    Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
    Front Oncol; 2023; 13():1283480. PubMed ID: 37795439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: Mucinous adenocarcinoma of the rectum: a whole genome sequencing study.
    Reynolds IS; Thomas V; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Burke JP; Furney SJ
    Front Oncol; 2023; 13():1229013. PubMed ID: 37456242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: Investigation of a novel deep learning-based computed tomography perfusion mapping framework for functional lung avoidance radiotherapy.
    Ren G; Lam SK; Zhang J; Xiao H; Cheung AL; Ho WY; Qin J; Cai J
    Front Oncol; 2022; 12():1005287. PubMed ID: 36132139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China.
    Guo LW; Lyu ZY; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Cao XQ; Liu SZ; Sun XB; Zhang JG; Zhang SK
    Front Oncol; 2022; 12():871848. PubMed ID: 35311146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.
    Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
    Front Oncol; 2023; 13():1218781. PubMed ID: 37274238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.
    Jain AS; Prasad A; Pradeep S; Dharmashekar C; Achar RR; Silina E; Stupin V; Amachawadi RG; Prasad SK; Pruthvish R; Syed A; Shivamallu C; Kollur SP
    Front Oncol; 2021; 11():822865. PubMed ID: 34988031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erratum: Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum].
    Onco Targets Ther; 2023; 16():279-280. PubMed ID: 37101798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.
    Fan L; Fang M; Li Z; Tu W; Wang S; Chen W; Tian J; Dong D; Liu S
    Eur Radiol; 2019 Feb; 29(2):889-897. PubMed ID: 29967956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.
    Liu H; Xu Y; Liang K; Liu R
    Front Oncol; 2021; 11():817747. PubMed ID: 35004334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma.
    Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G
    Front Oncol; 2023; 13():1282120. PubMed ID: 37766865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress.
    Albahde MAH; Abdrakhimov B; Li GQ; Zhou X; Zhou D; Xu H; Qian H; Wang W
    Front Oncol; 2024; 14():1414456. PubMed ID: 38751807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs.
    Dragomir M; Calin GA
    Front Oncol; 2018; 8():307. PubMed ID: 30280089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.
    Hou T; Jiang S; Wang Y; Xie Y; Zhang H; Feng Y; Ma F; Ma J; Liu X; Hu C
    Front Oncol; 2021; 11():705406. PubMed ID: 34150669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.
    Bai L; Pfeifer T; Gross W; De La Torre C; Zhao S; Liu L; Schaefer M; Herr I
    Front Oncol; 2022; 12():889215. PubMed ID: 35433483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.
    Huang SS; Liao WY; Hsu CC; Chan TS; Liao TY; Yang PM; Chen LT; Sung SY; Tsai KK
    Front Oncol; 2021; 11():718849. PubMed ID: 34239806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis.
    Zhang W; Wang W; Wu J; Tian J; Yan W; Yuan Y; Yao Y; Shang A; Quan W
    Front Oncol; 2022; 12():1118042. PubMed ID: 36591456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients.
    Jing K; Zhao H; Cai J; Chen L; Zheng P; Ouyang L; Li G; Wang R
    Front Oncol; 2023; 13():1353702. PubMed ID: 38192623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy.
    Zhao N; Yi Y; Cao W; Fu X; Mei N; Li C
    Front Oncol; 2022; 12():1069999. PubMed ID: 36582794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.
    Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L
    Front Oncol; 2024; 14():1381151. PubMed ID: 38463236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.